The Oncology Drug Shortage

The issue of drug shortages is a persistent and complex one. There is an urgent need for a wide-ranging, multifaceted strategy to address drug shortages and bold, comprehensive solutions. Professional societies, such as the American Society of Clinical Oncology (ASCO), have a crucial role to play in advocating for governmental action and raising awareness to combat these critical shortages of lifesaving and life-prolonging medications. ASCO’s proposed solutions focus on reforming economic incentives related to generic drug pricing to foster market sustainability and encourage investment in high-quality manufacturing. This will require significant collaboration, including government intervention and public-private partnerships.